IL6 and Charcot-Marie-Tooth disease: The relevance of the CMT neuropathy score (CMTNS) can be further improved by objective measurements in humans in addition to the electrophysiological recording of the compound muscle action potential (CMAP) to also include plasma levels of IL-6 and MRI [23,24].